These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 33841618)

  • 1. Safety and Pharmacokinetics of FMX103 (1.5% Minocycline Topical Foam) in Subjects with Moderate-to-Severe Papulopustular Rosacea under Maximum-use Treatment Conditions.
    Jones TM; Stuart I
    J Clin Aesthet Dermatol; 2021 Mar; 14(3):E53-E57. PubMed ID: 33841618
    [No Abstract]   [Full Text] [Related]  

  • 2. A Phase II, Randomized, Double-Blind Clinical Study Evaluating the Safety, Tolerability, and Efficacy of a Topical Minocycline Foam, FMX103, for the Treatment of Facial Papulopustular Rosacea.
    Mrowietz U; Kedem TH; Keynan R; Eini M; Tamarkin D; Rom D; Shirvan M
    Am J Clin Dermatol; 2018 Jun; 19(3):427-436. PubMed ID: 29396702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Open-label Extension Study Evaluating Long-term Safety and Efficacy of FMX103 1.5% Minocycline Topical Foam for the Treatment of Moderate-to-Severe Papulopustular Rosacea.
    Stein Gold L; Del Rosso JQ; Kircik L; Bhatia ND; Hooper D; Nahm W; Stuart I
    J Clin Aesthet Dermatol; 2020 Nov; 13(11):44-49. PubMed ID: 33282103
    [No Abstract]   [Full Text] [Related]  

  • 4. Minocycline 1.5% foam for the topical treatment of moderate to severe papulopustular rosacea: Results of 2 phase 3, randomized, clinical trials.
    Gold LS; Del Rosso JQ; Kircik L; Bhatia ND; Hooper D; Nahm WK; Stuart I
    J Am Acad Dermatol; 2020 May; 82(5):1166-1173. PubMed ID: 32004648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic Comparison of Once-Daily Topical Minocycline Foam 4% vs Oral Minocycline for Moderate-to-Severe Acne.
    Jones TM; Ellman H; deVries T
    J Drugs Dermatol; 2017 Oct; 16(10):1022-1028. PubMed ID: 29036256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multicentre, randomized, double-masked, parallel group, vehicle-controlled phase IIb study to evaluate the safety and efficacy of 1% and 3% topical minocycline gel in patients with papulopustular rosacea.
    Webster G; Draelos ZD; Graber E; Lee MS; Dhawan S; Salman M; Magrath GN
    Br J Dermatol; 2020 Sep; 183(3):471-479. PubMed ID: 31907924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose isotretinoin versus minocycline in the treatment of rosacea.
    Shemer A; Gupta AK; Kassem R; Sharon N; Quinlan EM; Galili E
    Dermatol Ther; 2021 Jul; 34(4):e14986. PubMed ID: 33993601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vehicle Effects on the Rosacea Skin Barrier.
    Draelos ZD
    J Drugs Dermatol; 2021 Jun; 20(6):630-632. PubMed ID: 34076389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Pharmacokinetics of Oxymetazoline Cream Following Topical Facial Administration for the Treatment of Erythema Associated With Rosacea.
    Kuang AW; DuBois J; Attar M; Ahluwalia G
    J Drugs Dermatol; 2018 Feb; 17(2):213-220. PubMed ID: 29462230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minocycline Extended-Release Comparison with Doxycycline for the Treatment of Rosacea: A Randomized, Head-to-Head, Clinical Trial.
    Tsianakas A; Pieber T; Baldwin H; Feichtner F; Alikunju S; Gautam A; Shenoy S; Singh P; Sidgiddi S
    J Clin Aesthet Dermatol; 2021 Dec; 14(12):16-23. PubMed ID: 35096250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of papulopustular rosacea with sodium sulfacetamide 10%/sulfur 5% emollient foam.
    Trumbore MW; Goldstein JA; Gurge RM
    J Drugs Dermatol; 2009 Mar; 8(3):299-304. PubMed ID: 19271381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current topical and systemic approaches to treatment of rosacea.
    Korting HC; Schöllmann C
    J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):876-82. PubMed ID: 19508315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term safety and efficacy of once-daily topical brimonidine tartrate gel 0.5% for the treatment of moderate to severe facial erythema of rosacea: results of a 1-year open-label study.
    Moore A; Kempers S; Murakawa G; Weiss J; Tauscher A; Swinyer L; Liu H; Leoni M
    J Drugs Dermatol; 2014 Jan; 13(1):56-61. PubMed ID: 24385120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Review of Systemic Minocycline Side Effects and Topical Minocycline as a Safer Alternative for Treating Acne and Rosacea.
    Martins AM; Marto JM; Johnson JL; Graber EM
    Antibiotics (Basel); 2021 Jun; 10(7):. PubMed ID: 34206485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical Minocycline Foam 4%: A Review in Acne Vulgaris.
    Paik J
    Am J Clin Dermatol; 2020 Jun; 21(3):449-456. PubMed ID: 32468355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness and safety of doxycycline 40 mg (30-mg immediate-release and 10-mg delayed-release beads) once daily as add-on therapy to existing topical regimens for the treatment of papulopustular rosacea: results from a community-based trial.
    Del Rosso JQ
    Cutis; 2010 Nov; 86(5 Suppl):16-25. PubMed ID: 21229827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Very low-dose isotretinoin in mild to moderate papulopustular rosacea; a retrospective review of 52 patients.
    Rademaker M
    Australas J Dermatol; 2018 Feb; 59(1):26-30. PubMed ID: 27435665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minocycline Topical Foam: A New Drug for the Treatment of Acne.
    Onge ES; Mobley WC
    Ann Pharmacother; 2021 Jan; 55(1):105-110. PubMed ID: 32618475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ozonated Hydrotherapy Combined with LED Yellow Light Irradiation and Oral Minocycline Treatment for Mild to Moderate Papulopustular Rosacea: A Comparative Retrospective Study.
    Wei J; Zhang C; Leng Y; Li M; Du L; Cao Z; Zhu X; Han C; Meng L
    Clin Cosmet Investig Dermatol; 2024; 17():1193-1202. PubMed ID: 38800354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical Ivermectin in the Treatment of Papulopustular Rosacea: A Systematic Review of Evidence and Clinical Guideline Recommendations.
    Ebbelaar CCF; Venema AW; Van Dijk MR
    Dermatol Ther (Heidelb); 2018 Sep; 8(3):379-387. PubMed ID: 29943217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.